UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 142

Sortiert nach

The prognostic impact of PD-L1 and CD8 expression in anal cancer patients treated with chemoradiotherapy

Frontiers in oncology, 2022-10, Vol.12, p.1000263-1000263

2022

Link zum Volltext

Verfügbarkeit prüfen

Treatment and outcomes in undifferentiated and dedifferentiated endometrial carcinoma

Journal of Gynecologic Oncology, 2022, 33(3), , pp.1-12

2022

Link zum Volltext

Verfügbarkeit prüfen

Another Whipple's triad? Pericardial, myocardial and valvular disease in an unusual case presentation from a Canadian perspective

BMC cardiovascular disorders, 2019-12, Vol.19 (1), p.312-312, Article 312

2019

Link zum Volltext

Verfügbarkeit prüfen

Cancer cell genotype associated tumor immune microenvironment exhibits differential response to therapeutic STING pathway activation in high-grade serous ovarian cancer

Journal for immunotherapy of cancer, 2023-04, Vol.11 (4), p.e006170

2023

Link zum Volltext

Verfügbarkeit prüfen

Adult lifetime alcohol consumption and invasive epithelial ovarian cancer risk in a population-based case–control study

Gynecologic oncology, 2016-02, Vol.140 (2), p.277-284

2016

Link zum Volltext

Verfügbarkeit prüfen

Incidental Nonuterine High-grade Serous Carcinomas Arise in the Fallopian Tube in Most Cases: Further Evidence for the Tubal Origin of High-grade Serous Carcinomas

The American journal of surgical pathology, 2015-03, Vol.39 (3), p.357-364

2015

Link zum Volltext

Verfügbarkeit prüfen

Clinicopathological analysis of endometrial carcinomas harboring somatic POLE exonuclease domain mutations

Modern pathology, 2015-04, Vol.28 (4), p.505-514

2015

Link zum Volltext

Verfügbarkeit prüfen

Clear cell carcinoma of the ovary: A report from the first Ovarian Clear Cell Symposium, June 24th, 2010

Gynecologic oncology, 2011-05, Vol.121 (2), p.407-415

2011

Link zum Volltext

Verfügbarkeit prüfen

Prognostically relevant gene signatures of high-grade serous ovarian carcinoma

The Journal of clinical investigation, 2013-01, Vol.123 (1), p.517-525

2013

Link zum Volltext

Verfügbarkeit prüfen

Efficient molecular subtype classification of high-grade serous ovarian cancer

The Journal of pathology, 2015-07, Vol.236 (3), p.272-277

2015

Link zum Volltext

Verfügbarkeit prüfen

Undifferentiated Endometrial Carcinomas Show Frequent Loss of Core Switch/Sucrose Nonfermentable Complex Proteins

The American journal of surgical pathology, 2018-01, Vol.42 (1), p.76-83

2018

Link zum Volltext

Verfügbarkeit prüfen

POLE exonuclease domain mutation predicts long progression-free survival in grade 3 endometrioid carcinoma of the endometrium

Gynecologic oncology, 2014-07, Vol.134 (1), p.15-19

2014

Link zum Volltext

Verfügbarkeit prüfen

Mucinous carcinomas of the ovary and colorectum: different organ, same dilemma

The lancet oncology, 2011-10, Vol.12 (11), p.1071-1080

2011

Link zum Volltext

Verfügbarkeit prüfen

Loss of switch/sucrose non‐fermenting complex protein expression in undifferentiated gastrointestinal and pancreatic carcinomas

Histopathology, 2020-07, Vol.77 (1), p.46-54

2020

Link zum Volltext

Verfügbarkeit prüfen

Ovarian carcinoma subtypes are different diseases: implications for biomarker studies

PLoS medicine, 2008-12, Vol.5 (12), p.e232-e232

2008

Link zum Volltext

Verfügbarkeit prüfen

Napsin A: Another milestone in the subclassification of ovarian carcinoma

American journal of clinical pathology, 2014-12, Vol.142 (6), p.735-737

2014

Link zum Volltext

Verfügbarkeit prüfen

Malignancy is in the eye of the beholder: Pathologic diagnosis of challenging follicular neoplasms in the era of noninvasive follicular thyroid neoplasms with papillary-like nuclear features and immunohistochemical and molecular adjuncts

Surgery, 2021-01, Vol.169 (1), p.22-26

2021

Link zum Volltext

Verfügbarkeit prüfen

Mesonephric‐like adenocarcinoma harbours characteristic copy number variations and a distinct DNA methylation signature closely related to mesonephric adenocarcinoma of the cervix

The Journal of pathology, 2024-01, Vol.262 (1), p.4-9

2024

Link zum Volltext

Verfügbarkeit prüfen

Systematic analysis of immune infiltrates in high-grade serous ovarian cancer reveals CD20, FoxP3 and TIA-1 as positive prognostic factors

PloS one, 2009-07, Vol.4 (7), p.e6412-e6412

2009

Link zum Volltext

Verfügbarkeit prüfen

BRCA1 and BRCA2 mutations correlate with TP53 abnormalities and presence of immune cell infiltrates in ovarian high-grade serous carcinoma

Modern pathology, 2012-05, Vol.25 (5), p.740-750

2012

Link zum Volltext

Verfügbarkeit prüfen

Smoking may modify the association between neoadjuvant chemotherapy and survival from ovarian cancer

Gynecologic oncology, 2016-01, Vol.140 (1), p.124-130

2016

Link zum Volltext

Verfügbarkeit prüfen

Pleural Malignant Mesotheliomas Do Not Demonstrate SWItch/Sucrose Nonfermentable (SWI/SNF) Complex Deficiency

The American journal of surgical pathology, 2021-02, Vol.45 (2), p.290

2021

Link zum Volltext

Verfügbarkeit prüfen

Differences in tumor type in low-stage versus high-stage ovarian carcinomas

International journal of gynecological pathology, 2010-05, Vol.29 (3), p.203

2010

Link zum Volltext

Verfügbarkeit prüfen

Histopathological features of endometrial carcinomas associated with POLE mutations: implications for decisions about adjuvant therapy

Histopathology, 2016-05, Vol.68 (6), p.916-924

2016

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 142

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(134)
Mit Volltextzugriff
(119)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

The prognostic impact of PD-L1 and CD8 expression in anal cancer patients treated with chemoradiotherapy

Treatment and outcomes in undifferentiated and dedifferentiated endometrial carcinoma

Another Whipple's triad? Pericardial, myocardial and valvular disease in an unusual case presentation from a Canadian perspective

Cancer cell genotype associated tumor immune microenvironment exhibits differential response to therapeutic STING pathway activation in high-grade serous ovarian cancer

Adult lifetime alcohol consumption and invasive epithelial ovarian cancer risk in a population-based case–control study

Incidental Nonuterine High-grade Serous Carcinomas Arise in the Fallopian Tube in Most Cases: Further Evidence for the Tubal Origin of High-grade Serous Carcinomas

Clinicopathological analysis of endometrial carcinomas harboring somatic POLE exonuclease domain mutations

Clear cell carcinoma of the ovary: A report from the first Ovarian Clear Cell Symposium, June 24th, 2010

Prognostically relevant gene signatures of high-grade serous ovarian carcinoma

Efficient molecular subtype classification of high-grade serous ovarian cancer

Undifferentiated Endometrial Carcinomas Show Frequent Loss of Core Switch/Sucrose Nonfermentable Complex Proteins

POLE exonuclease domain mutation predicts long progression-free survival in grade 3 endometrioid carcinoma of the endometrium

Mucinous carcinomas of the ovary and colorectum: different organ, same dilemma

Loss of switch/sucrose non‐fermenting complex protein expression in undifferentiated gastrointestinal and pancreatic carcinomas

Ovarian carcinoma subtypes are different diseases: implications for biomarker studies

Napsin A: Another milestone in the subclassification of ovarian carcinoma

Malignancy is in the eye of the beholder: Pathologic diagnosis of challenging follicular neoplasms in the era of noninvasive follicular thyroid neoplasms with papillary-like nuclear features and immunohistochemical and molecular adjuncts

Mesonephric‐like adenocarcinoma harbours characteristic copy number variations and a distinct DNA methylation signature closely related to mesonephric adenocarcinoma of the cervix

Systematic analysis of immune infiltrates in high-grade serous ovarian cancer reveals CD20, FoxP3 and TIA-1 as positive prognostic factors

BRCA1 and BRCA2 mutations correlate with TP53 abnormalities and presence of immune cell infiltrates in ovarian high-grade serous carcinoma

Mutation of FOXL2 in Granulosa-Cell Tumors of the Ovary

Smoking may modify the association between neoadjuvant chemotherapy and survival from ovarian cancer

Pleural Malignant Mesotheliomas Do Not Demonstrate SWItch/Sucrose Nonfermentable (SWI/SNF) Complex Deficiency

Differences in tumor type in low-stage versus high-stage ovarian carcinomas

Histopathological features of endometrial carcinomas associated with POLE mutations: implications for decisions about adjuvant therapy

Suchergebnisse filtern